We are live on ! Find out more
Walleye Capital

Walleye Capital Portfolio holdings

AUM $24B
1-Year Est. Return 37.67%
This Fund
S&P 500
This Quarter Est. Return
+4.79%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
AUM
$32.6B
AUM Growth
+$5.94B
Cap. Flow
+$4.68B
Cap. Flow %
14.35%
Top 10 Hldgs %
28.49%
Holding
5,277
New
882
Increased
1,986
Reduced
1,465
Closed
789

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$248M
2
NVDA icon
NVIDIA
NVDA
+$246M
3
TSLA icon
Tesla
TSLA
+$236M
4
AVGO icon
Broadcom
AVGO
+$209M
5
PLTR icon
Palantir
PLTR
+$171M

Sector Composition

Rank Sector Weight
1 Technology 7.32%
2 Healthcare 7.04%
3 Consumer Discretionary 5.39%
4 Industrials 4.55%
5 Financials 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLW icon
4026
Corning
GLW
$107B
$48.5K ﹤0.01%
554
-50,465
-99% -$4.35M
CVI icon
4027
CALL
CVR Energy
CVI
$3.48B
$48.3K ﹤0.01%
1,900
TNET icon
4028
TriNet
TNET
$3.23B
$48.3K ﹤0.01%
816
-1,077
-57% -$64K
OSG
4029
PUT
Octave Specialty Group
OSG
$257M
$48.2K ﹤0.01%
6,200
ACGL icon
4030
PUT
Arch Capital
ACGL
$35.7B
$48K ﹤0.01%
500
-6,100
-92% -$558K
PLTK icon
4031
CALL
Playtika
PLTK
$1.53B
$47.8K ﹤0.01%
12,100
-6,800
-36% -$26.6K
RYAM icon
4032
PUT
Rayonier Advanced Materials
RYAM
$562M
$47.7K ﹤0.01%
8,100
-7,600
-48% -$49.4K
TWST icon
4033
PUT
Twist Bioscience
TWST
$5.32B
$47.6K ﹤0.01%
+1,500
New +$46.8K
CCCC icon
4034
CALL
C4 Therapeutics
CCCC
$389M
$47.6K ﹤0.01%
24,900
+400
+2% +$948
BOLD
4035
Boundless Bio
BOLD
$55.7M
$47.5K ﹤0.01%
39,624
BVN icon
4036
PUT
Compañía de Minas Buenaventura
BVN
$7.68B
$47.3K ﹤0.01%
+1,700
New +$42.4K
PUBM icon
4037
CALL
PubMatic
PUBM
$608M
$47K ﹤0.01%
+5,300
New +$46.2K
CMPS
4038
CALL
Compass Pathways
CMPS
$1.47B
$46.9K ﹤0.01%
6,800
-3,400
-33% -$20.7K
FLWS icon
4039
CALL
1-800-Flowers.com
FLWS
$252M
$46.8K ﹤0.01%
11,900
-60,500
-84% -$238K
CRON
4040
Cronos Group
CRON
$1.07B
$46.7K ﹤0.01%
+17,762
New +$45.9K
SKIN icon
4041
SkinHealth Systems
SKIN
$83.4M
$46.7K ﹤0.01%
33,598
-209,804
-86% -$303K
PLCE icon
4042
Children's Place
PLCE
$53.8M
$46.4K ﹤0.01%
11,659
+6,155
+112% +$44.1K
TROX icon
4043
Tronox
TROX
$967M
$46.2K ﹤0.01%
11,068
-529,820
-98% -$2.02M
SBXD.WS
4044
SilverBox Corp IV Warrants
SBXD.WS
$46.1K ﹤0.01%
164,542
GLOB icon
4045
PUT
Globant
GLOB
$1.65B
$45.8K ﹤0.01%
700
-32,700
-98% -$2.06M
SVCO
4046
Silvaco Group
SVCO
$232M
$45.5K ﹤0.01%
11,247
-46,001
-80% -$228K
FN icon
4047
CALL
Fabrinet
FN
$14.9B
$45.5K ﹤0.01%
100
OSK icon
4048
Oshkosh
OSK
$8.82B
$45.2K ﹤0.01%
360
-31,099
-99% -$4M
WRD
4049
CALL
WeRide Inc
WRD
$1.9B
$45.1K ﹤0.01%
5,200
-4,000
-43% -$37.2K
BTBT icon
4050
PUT
Bit Digital
BTBT
$428M
$45K ﹤0.01%
23,800
-15,200
-39% -$43.9K

Similar funds

Walleye Capital's Q4 2025 Portfolio in Review

As of Q4 2025, Walleye Capital held 5,277 positions worth $32.6B, up 22% from $26.7B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Walleye Capital deployed $4.68B of net new capital in Q4 2025, opening 882 new positions and adding to 1,986 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 6,616,070 shares worth $4.53B.

By sector, the portfolio is most concentrated in Technology at 7.3% of assets, down from 9.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $248M trimmed.

  • Walleye Capital's largest Q4 2025 buy was iShares Core S&P 500 ETF: 6,616,070 shares worth $4.53B.
  • Walleye Capital added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $136M increase.
  • Walleye Capital's biggest Q4 2025 reduction was Apple, cutting an estimated $248M.
  • Walleye Capital fully exited Mohawk Industries in Q4 2025, selling an estimated $39.8M.
  • Walleye Capital's ten largest holdings make up 28% of its $32.6B portfolio in Q4 2025.
  • Walleye Capital opened 882 new positions and closed 789 in Q4 2025.
  • Walleye Capital's portfolio value rose 22% quarter-over-quarter to $32.6B.

Based on Walleye Capital's 13F filing for Q4 2025, filed 13 Feb 2026.